Nexalin Technology, Inc. (NXL) vs Catheter Precision, Inc. (VTAK)
Nexalin Technology, Inc. and Catheter Precision, Inc. are both Medical Devices companies. Nexalin Technology, Inc. is the larger, with a market value of $3.6M against $3.0M — 1.2× the size. Catheter Precision, Inc. grew revenue faster over the last twelve months: 219.2% against 24.3%. Catheter Precision, Inc. has the higher net margin (−711.5% vs −4,138.5%) and the higher return on invested capital (−64.4% vs −1,108.8%). Across the 18 metrics below, Catheter Precision, Inc. leads on 13 and Nexalin Technology, Inc. on 5.
Valuation
Profitability
| Metric | NXL | VTAK | Medical Devices median |
|---|---|---|---|
| Gross margin | 86.14% | 47.73% | 56.01% |
| Operating margin | (4,201.66%) | (1,000.26%) | (15.03%) |
| Net margin | (4,138.49%) | (711.49%) | (20.40%) |
| Free cash flow margin | (2,917.96%) | (489.45%) | (7.24%) |
| Return on equity | (240.25%) | (115.04%) | (15.32%) |
| Return on assets | (187.89%) | (43.65%) | (19.72%) |
| Return on invested capital | (1,108.82%) | (64.41%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack